Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer

BACKGROUND: Hypofractionated radiotherapy in locally advanced limited-stage small cell lung cancer is preferred in many Western countries but not used regularly in the United States. We examined practice patterns and overall survival with definitive hypofractionated radiotherapy and chemotherapy vs....

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Nadia A., Jin, Lan, Sasse, Alexander W., Amini, Arya, Verma, Vivek, Lester-Coll, Nataniel H., Chen, Po-Han, Decker, Roy H., Park, Henry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902118/
https://www.ncbi.nlm.nih.gov/pubmed/35280466
http://dx.doi.org/10.21037/jtd-21-1566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902118/
https://www.ncbi.nlm.nih.gov/pubmed/35280466
http://dx.doi.org/10.21037/jtd-21-1566

Ejemplares similares